Chile starts fourth vaccine dose as coronavirus cases rise

Chile is implementing a fourth vaccination dose for some citizens as the number of daily coronavirus infections rises

Via AP news wire
Monday 10 January 2022 14:44
Virus Outbreak Chile
Virus Outbreak Chile

Chile is implementing a fourth vaccination dose for some citizens as the number of daily coronavirus infections rises.

President Sebastián Piñera was present on Monday when two adults with immunosuppression problems received a fourth vaccination for COVID-19 at a Santiago hospital.

Chile is applying a fourth dose early because the current daily infection rate of 4,000 coronavirus cases could rise to 10,000 or more, Piñera said.

Vaccination with a fourth dose for the immunosuppressed will end on Feb. 7. Then the program will turn to people over 55 years old who had a third dose at least six months ago.

Chile, which has 19 million people, had planned to start with the fourth dose in February. The sharp increase in infections in neighboring Argentina Bolivia and Peru contributed to its decision to advance the process.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in